Woodward Diversified Capital
Woodward Diversified Capital, founded in 2019 and based in Bakersfield, California, is a private equity firm that specializes in advanced investment strategies and wealth management solutions for high net worth individuals and family offices. The firm's partners are recognized for their innovative and responsive investment approaches, drawing on a long-standing entrepreneurial tradition. Woodward Diversified Capital has developed broad transaction capabilities and has a diverse portfolio that spans various industries. As a Registered Investment Adviser, the firm is dedicated to delivering tailored financial services that meet the unique needs of its clients.
Genelux Corporation is a clinical-stage biopharmaceutical company that specializes in oncolytic viral immunotherapies aimed at treating aggressive and hard-to-manage solid tumors. The company's lead product candidate, GL-ONC1, is an attenuated vaccinia virus designed to induce significant regression and elimination of various solid tumors while sparing healthy tissues. This candidate incorporates Green Fluorescent Protein (GFP), which aids in the imaging of tumors and metastases, thus assisting in cancer diagnosis and staging. Currently, GL-ONC1 is undergoing Phase I/II clinical trials in the United States and Europe, with additional trials planned for the future. The therapy has demonstrated good tolerability with minimal side effects and early indications of anti-tumor efficacy. Genelux also has a diverse pipeline that includes other promising products like Olvi-Vec, reflecting its commitment to advancing innovative cancer treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.